Anesthesia and analgesia during and after surgery in neonates

Clinical Therapeutics

Volumn 27, Issue 6, 2005, Pages 900-921

  Berde, Charles B ^a   Jaksic, Tom ^a   Lynn, Anne M ^b   Maxwell, Lynne G ^c   Soriano, Sulpicio G ^a   Tibboel, Dick ^d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Analgesia; Anesthesia; Neonate; Newborn; Postoperative care

Indexed keywords

ACETYLSALICYLIC ACID; ALFENTANIL; ANALGESIC AGENT; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUPIVACAINE; CLONIDINE; FENTANYL; HYDROMORPHONE; HYPNOTIC SEDATIVE AGENT; IBUPROFEN; INDOMETACIN; KETAMINE; KETOROLAC; LIDOCAINE; LOCAL ANESTHETIC AGENT; METHADONE; MIDAZOLAM; MORPHINE; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE ANTAGONIST; PARACETAMOL; PROPACETAMOL; PROPOFOL; REMIFENTANIL; SUFENTANIL; UNINDEXED DRUG;

AGITATION; ANALGESIA; ANESTHESIA; BLEEDING; BLOOD CLOTTING DISORDER; BRADYCARDIA; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DIARRHEA; DISSOCIATIVE DISORDER; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG OVERDOSE; GASTROINTESTINAL DISEASE; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPOTENSION; IRRITABILITY; KIDNEY DISEASE; KIDNEY FAILURE; LETHARGY; LIVER DISEASE; MYOCARDIAL DISEASE; NAUSEA AND VOMITING; NEWBORN; NONHUMAN; PAIN; PATENT DUCTUS ARTERIOSUS; PRURITUS; PULMONARY HYPERTENSION; QUESTIONNAIRE; RESPIRATION DEPRESSION; REYE SYNDROME; SEDATION; SEIZURE; SIDE EFFECT; STOMACH ULCER; SURGICAL TECHNIQUE; SWEATING; TACHYCARDIA; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 25844523690     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.06.020     Document Type: Conference Paper

References (189)

1. Agency for Healthcare Research and Quality. HCUPnet: Healthcare Cost and Utilization Project Available at: http:// hcup.ahrq.gov/HCUPnet.asp. Accessed November 24, 2004.
2. Kinney JM. Metabolic responses of the critically ill patient. Crit Care Clin. 1995;11:569-585.
3. Cuthbertson DP. Post-traumatic metabolism: A multidisciplinary challenge. Surg Clin North Am. 1978;58:1045-1054.
4. Robinson S, Gregory GA. Fentanyl-air-oxygen anesthesia for ligation of patent ductus arteriosus in preterm infants. Anesth Analg. 1981;60:331-334.
5. Lerman J, Robinson S, Willis MM, Gregory GA. Anesthetic requirements for halothane in young children 0-1 month and 1-6 months of age. Anesthesiology. 1983;59:421-424.
6. Rodgers A, Walker N, Schug S, et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: Results from overview of randomised trials. BMJ. 2000;321:1493. Comment.
7. Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002;183:630-641.
8. Basse L, Madsen JL, Kehlet H. Normal gastrointestinal transit after colonic resection using epidural analgesia, enforced oral nutrition and laxative. Br J Surg. 2001;88: 1498-1500.
9. Brodner G, Van Aken H, Hertle L, et al. Multimodal perioperative management-combining thoracic epidural analgesia, forced mobilization, and oral nutrition-reduces hormonal and metabolic stress and improves convalescence after major urologic surgery. Anesth Analg. 2001;92:1594-1600.
10. Basse L, Raskov HH, Hjort Jakobsen D, et al. Accelerated postoperative recovery programme after colonic resection improves physical performance, pulmonary function and body composition. Br J Surg. 2002;89:446-453.
11. Holte K, Kehlet H. Epidural anaesthesia and analgesia-effects on surgical stress responses and implications for postoperative nutrition. Clin Nutr. 2002;21:199-206.
12. Kehlet H. Surgical stress response: Does endoscopic surgery confer an advantage? World J Surg. 1999;23:801-807.
13. Garza JJ, Shew SB, Keshen TH, et al. Energy expenditure in ill premature neonates. J Pediatr Surg. 2002;37:289-293.
14. Jaksic T, Shew SB, Keshen TH, et al. Do critically ill surgical neonates have increased energy expenditure? J Pediatr Surg. 2001;36:63-67.
15. Keshen TH, Miller RG, Jahoor F, Jaksic T. Stable isotopic quantitation of protein metabolism and energy expenditure in neonates on- and post-extracorporeal life support. J Pediatr Surg. 1997;32:958-962.
16. Shew SB, Jaksic T. The metabolic needs of critically ill children and neonates. Semin Pediatr Surg. 1999;8:131-139.
17. Shew SB, Beckett PR, Keshen TH, et al. Validation of a [13C]bicarbonate tracer technique to measure neonatal energy expenditure. Pediatr Res. 2000;47:787-791.
18. Bouwmeester NJ, Anand KJ, van Dijk M, et al. Hormonal and metabolic stress responses after major surgery in children aged 0-3 years: A double-blind, randomized trial comparing the effects of continuous versus intermittent morphine. Br J Anaesth. 2001;87:390-399.
19. Bouwmeester NJ, Hop W, Tibboel D. Metabolic stress responses in postoperative children aged 0-3 years. Paediatr Anaesth. 2000;10:690-691.
20. Jaksic T. Effective and efficient nutritional support for the injured child. Surg Clin North Am. 2002;82:379-391.
21. Anand KJ, Brown MJ, Bloom SR, Aynsley-Green A. Studies on the hormonal regulation of fuel metabolism in the human newborn infant undergoing anaesthesia and surgery. Horm Res. 1985;22:115-128.
22. Anand KJ, Brown MJ, Causon RC, et al. Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg. 1985; 20:41-48.
23. Anand KJ, Sippell WC, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: Effects on the stress response [published correction appears in Lancet. 1987;1:234]. Lancet. 1987;1:62-66.
24. Anand KJ, Aynsley-Green A. Measuring the severity of surgical stress in newborn infants. J Pediatr Surg. 1988;23:297-305.
25. Anand KJ, Sippell WC, Schofield NM, Aynsley-Green A. Does halothane anaesthesia decrease the metabolic and endocrine stress responses of newborn infants undergoing operation? Br Med J (Clin Res Ed). 1988;296:668-672.
26. Vaster M. The dose response of fentanyl in neonatal anesthesia. Anesthesiology. 1987;66:433-435.
27. Liu D, Diorio J, Tannenbaum B, et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science. 1997;277:1659-1662.
28. Ruda MA, Ling QD, Hohmann AG, et al. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science. 2000;289:628-631.
29. Anand KJ, Coskun V, Thrivikraman KV, et al. Long-term behavioral effects of repetitive pain in neonatal rat pups. Physiol Behav. 1999;66: 627-637.
30. Bhutta AT, Rovnaghi C, Simpson PM, et al. Interactions of inflammatory pain and morphine in infant rats: Long-term behavioral effects. Physiol Behav. 2001;73:51-58.
31. Rahman W, Fitzgerald M, Aynsley-Green A, Dickenson AH. The effects of neonatal exposure to inflammation and/or morphine on neuronal responses and morphine analgesia in adult rats. In: Jensen TS, Turner JA, Wiesenfeld-Hallin Z, eds. Proceedings of the 8th World Congress on Pain. Seattle, Wash: IASP Press; 1997: 783-794.
32. Tiret L, Nivoche Y, Hatton F, et al. Complications related to anaesthesia in infants and children. A prospective survey of 40240 anaesthetics. Br J Anaesth. 1988;61:263-269.
33. Morray JP, Geiduschek JM, Ramamoorthy C, et al. Anesthesia-related cardiac arrest in children: Initial findings of the Pediatric Perioperative Cardiac Arrest (POCA) Registry. Anesthesiology. 2000;93:6-14.
34. Gogenur I, Rosenberg-Adamsen S, Kiil C, et al. Laparoscopic cholecystectomy causes less sleep disturbance than open abdominal surgery. Surg Endosc. 2001;15:1452-1455.
35. Bisgaard T, Klarskov B, Trap R, et al. Microlaparoscopic vs conventional laparoscopic cholecystectomy: A prospective randomized double-blind trial. Surg Endosc. 2002;16:458-464.
36. Bisgaard T, Klarskov B, Kehlet H, Rosenberg J. Recovery after uncomplicated laparoscopic cholecystectomy. Surgery. 2002;132:817-825.
37. Kurds PS, DeSilva HN, Bernstein BA, et al. A comparison of the Mogen and Gomco clamps in combination with dorsal penile nerve block in minimizing the pain of neonatal circumcision [electronic article]. Pediatrics. 1999;103:e23.
38. Neal JM, Wilcox RT, Allen HW, Low DE. Near-total esophagectomy: The influence of standardized multimodal management and intraoperative fluid restriction. Reg Anesth Pain Med. 2003;28:328-334.
39. Schlossman H. The relationship between age and the action of atropine and morphine. J Pharmacol Exp Ther. 1937;60:14-31.
40. Kupferberg HJ, Way EL. Pharmacologic basis for the increased sensitivity of the newborn rat to morphine. J Pharmacol Exp Ther. 1963;141:105-112.
41. Way WL, Costley EC, Leongway E. Respiratory sensitivity of the newborn infant to meperidine and morphine. Clin Pharmacol Ther. 1965;11: 454-461.
42. Koren C, Butt W, Chinyanga H, et al. Postoperative morphine infusion in newborn infants: Assessment of disposition characteristics and safety. J Pediatr. 1985;107:963-967.
43. Lynn AM, Nespeca MK, Opheim KE, Slattery JT. Respiratory effects of intravenous morphine infusions in neonates, infants, and children after cardiac surgery. Anesth Analg. 1993; 77:695-701.
44. Lynn AM, Nespeca MK, Bratton SL, Shen DD. Ventilatory effects of morphine infusions in cyanotic versus acyanotic infants after thoracotomy. Paediatr Anaesth. 2003;13:12-17.
45. Lynn AM, Nespeca MK, Bratton SL, Shen DD. Intravenous morphine in postoperative infants: Intermittent bolus dosing versus targeted continuous infusions. Pain. 2000;88:89-95.
46. Hertzka RE, Gaundett IS, Fisher DM, Spellman MJ. Fentanyl-induced ventilatory depression: Effects of age. Anesthesiology. 1989;70:213-218.
47. Vaughn PR, Townsend SF, Thilo EH, et al. Comparison of continuous infusion of fentanyl to bolus dosing in neonates after surgery. J Pediatr Surg. 1996;31:1616-1623.
48. Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002;89:839-845.
49. Lynn A, Nespeca MK, Bratton SL, et al. Clearance of morphine in postoperative infants during intravenous infusion: The influence of age and surgery. Anesth Analg. 1998;86:958-963.
50. Lynn AM, Opheim KE, Tyler DC. Morphine infusion after pediatric cardiac surgery. Crit Care Med. 1984; 12:863-866.
51. Lynn AM, Slattery JT. Morphine pharmacokinetics in early infancy. Anesthesiology. 1987;66:136-139.
52. Sebel PS, Bovill JC, Schellekens AP, Hawker CD. Hormonal responses to high-dose fentanyl anaesthesia. A study in patients undergoing cardiac surgery. Br J Anaesth. 1981;53:941-948.
53. Hickey PR, Hansen DD. High-dose fentanyl reduces intraoperative ventricular fibrillation in neonates with hypoplastic left heart syndrome. J Clin Anesth. 1991;3:295-300.
54. Hansen DD, Hickey PR. Anesthesia for hypoplastic left heart syndrome: Use of high-dose fentanyl in 30 neonates. Anesth Analg. 1986;65:127-132.
55. Hansen J, James S, Burrington J, Whitfield J. The decreasing incidence of pneumothorax and improving survival of infants with congenital diaphragmatic hernia. J Pediatr Surg. 1984;19:385-388.
56. Anand KJ, Hansen DD, Hickey PR. Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology. 1990;73:661-670.
57. Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med. 1992;326:1-9.
58. Schraag S, Mohl U, Hirsch M, et al. Recovery from opioid anesthesia: The clinical implication of context-sensitive half-times. Anesth Analg. 1998;86:184-190.
59. Bailey JM. Context-sensitive half-times: What are they and how valuable are they in anaesthesiology? Clin Pharmacokinet. 2002;41:793-799.
60. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 1992;76:334-341.
61. Kuhls E, Gauntlett IS, Lau M, et al. Effect of increased in intra-abdominal pressure on hepatic extraction and clearance of fentanyl in neonatal lambs. J Pharmacol Exp Ther. 1995; 274:115-119.
62. Kapila A, Glass PS, Jacobs JR, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83:968-975.
63. Davis PJ, Galinkin J, McCowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles. Anesth Analg. 2001;93:1380-1386.
64. Galinkin JL, Davis PJ, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. II. Perioperative breathing patterns in neonates and infants with pyloric stenosis. Anesth Analg. 2001;93: 1387-1392.
65. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg. 1998;86:1307-1311.
66. Williams DC, Dickenson A, Fitzgerald M, Howard RF. Developmental regulation of codeine analgesia in the rat. Anesthesiology. 2004; 100:92-97.
67. Tobias JD, Berkenbosch JW, Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J. 2003;96:871-875.
68. Stile IL, Fort M, Wurzburger RJ, et al. The pharmacokinetics of naloxone in the premature newborn. Dev Pharmacol Ther. 1987;10:454-459.
69. Moreland TA, Brice JE, Walker CH, Parija AC. Naloxone pharmacokinetics in the newborn. Br J Urol Pharmacol. 1980;9:609-612.
70. Yaster M, Kost-Byerly S, Maxwell L. Opioid agonists and antagonists. In: Schechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children, and Adolescents. 2nd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003:181-224.
71. Gan TJ, Ginsberg B, Glass PS, et al. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiolgy. 1997;87:1075-1081.
72. Cepeda MS, Africano JM, Manrique AM, et al. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain. 2002;96:73-79.
73. Standifer KM, Pasternak GW. G proteins and opioid receptor-mediated signalling. Clin Signal. 1997;9:237-248.
74. Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain. 2000;84: 121-131.
75. Crain SM, Shen KF. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci U S A. 1995; 92:10540-10544.
76. Crain SM, Shen KF. Modulatory effects of Gs-coupled excitatory opioid receptor functions on opioid analgesia, tolerance, and dependence. Neurochem Res. 1996;21:1347-1351.
77. Maxwell LG, Kaufmann SC, Bitzer S, et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: A double-blind, prospective, randomized, controlled study. Anesth Analg. 100;4:953-958.
78. Sartain JB, Barry JJ, Richardson CA, Branagan HC. Effect of combining naloxone and morphine for intravenous patient-controlled analgesia. Anesthesiology. 2003;99:148-151.
79. Yuan CS, Wei G, Foss JF, et al. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: A double-blind randomized placebo-controlled trial. J Pharmacol Exp Ther. 2002;300:118-123.
80. Foss JF. A review of the potential role of methylnaltrexone in opioid bowel dysfunction. Am J Surg. 2001; 182(Suppl 5A):19S-26S.
81. Yuan CS, Foss JF. Oral methylnaltrexone for opioid-induced constipation. JAMA. 2000;284:1383-1384.
82. Yuan CS, Foss JF, O'Connor M, et al. Methylnaltrexone for reversal of constipation due to chronic methadone use: A randomized controlled trial. JAMA. 2000;283:367-372.
83. Yuan CS, Foss JF, Osinski J, et al. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 1997;61: 467-475.
84. Liu SS, Hodgson PS, Carpenter RL, Fricke JR Jr. ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia. Clin Pharmacol Ther. 2001;69:66-71.
85. Taguchi A, Sharma N, Saleem RM, et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N Engl Med. 2001;345:935-940.
86. Schmidt WK. Alvimopan (ADL 8-2698) is a novel peripheral opioid antagonist. Am J Surg. 2001;182 (Suppl 5A):27S-38S.
87. Tobias JD, Berkenbosch JW. Initial experience with dexmedecomidine in paediatric-aged patients. Paediatr Anaesth. 2002;12:171-175.
88. Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999; 283:70-74.
89. Soriano SC, Anand KJ, Rovnaghi CR, Hickey PR. Of mice and men: Should we extrapolate rodent experimental data to the care of human neonates? Anesthesiology. 2005;102: 866-888. Letter.
90. Hayashi H, Dikkes P, Soriano SG. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth. 2002;12:770-774.
91. Bhutta AT, Anand KJ. Vulnerability of the developing brain. Neuronal mechanisms. Clin Perinatol. 2002;29: 357-372.
92. Hickey PR, Hansen DD, Cramolini CM, et al. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology. 1985;62:287-293.
93. Saarenmaa E, Neuvonen PJ, Huttunen P, Fellman V. Ketamine for procedural pain relief in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2001;85:F53-F56.
94. Welborn LG, Rice LJ, Hannallah RS, et al. Postoperative apnea in former preterm infants: Prospective comparison of spinal and general anesthesia. Anesthesiology. 1990;72:838-842.
95. Tashiro C, Matsui Y, Nakano S, et al. Respiratory outcome in extremely premature infants following ketamine anaesthesia. Can J Anaesth. 1991; 38:287-291.
96. Jevtovic-Todorovic V, Hartman RE, Izumi Y, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003;23:876-882.
97. Jevtovic-Todorovic V, Beals J, Benshoff N, Olney JW. Prolonged exposure to inhalational anesthetic nitrous oxide kills neurons in adult rat brain. Neuroscience. 2003;122: 609-616.
98. Woodall AJ, Naruo H, Prince DJ, et al. Anesthetic treatment blocks synaptogenesis but not neuronal regeneration of cultured Lymnaea neurons. J Neurophysiol. 2003;90: 2232-2239. Epubjune 18, 2003.
99. Bray RJ. Propofol infusion syndrome in children. Paediatr Anaesth. 1998;8:491-499.
100. Wolf A, Weir P, Segar P, et al. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet. 2001;357:606-607.
101. Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: A simple name for a complex syndrome. Intensive Care Med. 2003;29: 1417-1425.
102. Playfor SD, Venkatesh K. Current patterns of propofol use in PICU in the United Kingdom and North America. Paediatr Anaesth. 2004;14:501-504.
103. Steur RJ, Perez RS, De Lange JJ. Dosage scheme for propofol in children under 3 years of age. Paediatr Anaesth. 2004;14:462-467.
104. Ohashi Y, Stowell JM, Nelson LE, et al. Nitrous oxide exerts age-dependent antinociceptive effects in Fischer rats. Pain. 2002;100:7-18.
105. Fujinaga M, Doone R, Davies MF, Maze M. Nitrous oxide lacks the antinociceptive effect on the tail flick test in newborn rats. Anesth Analg. 2000;91:6-10.
106. Swan HD, Crawford MW, Pua HL, et al. Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. Anesthesiology. 1999;91:667-671.
107. Mapleson WW. Effect of age on MAC in humans: A meta-analysis. Br J Anaesth. 1996;76:179-185.
108. Fisher DM, Zwass MS. MAC of deflurane in 60% nitrous oxide in infants and children. Anesthesiology. 1992;76:354-356.
109. Murray DJ, Forbes RB, Dull DL, Mahoney LT. Hemodynamic responses to nitrous oxide during inhalation anesthesia in pediatric patients. J Clin Anesth. 1991;3:14-19.
110. Russell IA, Miller Hance WC, Gregory G, et al. The safety and efficacy of sevoflurane anesthesia in infants and children with congenital heart disease. Anesth Analg. 2001;92:1152-1158.
111. Friesen RH, Henry DB. Cardiovascular changes in preterm neonates receiving isoflurane, halothane, fentanyl, and ketamine. Anesthesiology. 1986;64:238-242.
112. Allen CS, Cox CS Jr, White N, et al. Postoperative respiratory complications in ex-premature infants after inguinal herniorrhaphy. J Pediatr Surg. 1998;33:1095-1098.
113. Bell C, Dubose R, Seashore J, et al. Infant apnea detection after herniorrhaphy. J Clin Anesth. 1995;7: 219-223.
114. Cote CJ, Zaslavsky A, Downes JJ, et al. Postoperative apnea in former preterm infants after inguinal herniorrhaphy. A combined analysis. Anesthesiology. 1995;82:809-622.
115. Fisher DM. When is the ex-premature infant no longer at risk for apnea? Anesthesiology. 1995;82:807-808.
116. Frumiento C, Abajian JC, Vane DW. Spinal anesthesia for preterm infants undergoing inguinal hernia repair. Arch Surg. 2000;135:445-451.
117. Gregory CA, Steward DJ. Life-threatening perioperative apnea in the ex-"premie." Anesthesiology. 1983; 59:495-498.
118. Krane EJ, Haberkern CM, Jacobson LE. Postoperative apnea, bradycardia, and oxygen desaturation in formerly premature infants: Prospective comparison of spinal and general anesthesia. Anesth Analg. 1995;80:7-13.
119. Kurth CD, LeBard SE. Association of postoperative apnea, airway obtructions, and hypoxemia in former premature infants. Anesthesiology. 1991;75:22-26.
120. Welborn LG, Hannallah RS, Luban NL, et al. Anemia and postoperative apnea in former preterm infants. Anesthesiology. 1991;74:1003-1006.
121. Welborn LG, Hannallah RS, Fink R, et al. High-dose caffeine suppresses postoperative apnea in former preterm infants. Anesthesiology. 1989; 71:347-349.
122. Arnold JH, Truog RD, Scavone JM, Fenton T. Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion. Pediatr. 1991;119:639-643.
123. 2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase. J Neurosci Res. 2003;71:844-852.
124. Davies NM, Good RL, Roupe KA, Yanez JA. Cyclooxygenase-3: Axiom, dogma, anomaly, enigma or splice error?-Not as easy as 1, 2, 3. J Pharm Pharm Sci. 2004;7:217-226.
125. Sciulli MG, Seta F, Tacconelli S, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells. Br J Pharmacol. 2003;138:634-641.
126. van Lingen RA, Deinum HT, Quak CM, et al. Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants. Clin Pharmacol Ther. 1999;66:509-515.
127. Lin YC, Sussman HH, Benitz WE. Plasma concentrations after rectal administration of acetaminophen in preterm neonates. Paediatr Anaesth. 1997;7:457-459.
128. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children. J Pediatr. 1998;132:22-27.
129. Howard CR, Howard FM, Weitzman ML. Acecaminophen analgesia in neonatal circumcision: The effect on pain. Pediatrics. 1994;93: 641-646.
130. Macke JK. Analgesia for circumcision: Effects on newborn behavior and mother/infant interaction. J Obstet Gynecol Neonatal Nurs. 2001; 30:507-514.
131. Malnory M, Johnson TS, Kirby RS. Newborn behavioral and physiological responses to circumcision. Am J Matern Chid Nurs. 2003;28: 313-317.
132. Taddio A, Pollock N, Gilbert-MacLeod C. Combined analgesia and local anesthesia to minimize pain during circumcision. Arch Pediatr Adolesc Med. 2000;154:620-623.
133. Allegaert K, Van der Marel CD, Debeer A, et al. Pharmacokinetics of single dose intravenous propacetamol in neonates: Effect of gestational age. Arch Dis Child fetal Neonatal Ed. 2004;89:F25-F28.
134. Allegaert K, Verbesselt R, Devlieger H, et al. Cerebrospinal fluid pharmacokinetics of paracetamol after intravenous propacetamol in a former preterm infant. Br J Clin Pharmacol. 2004;57:224-225.
135. Allegaert K, Anderson BJ, Naulaers G, et al. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates. Eur J Clin Pharmacol. 2004;60:191-197.
136. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: A randomized trial at Ramathibodi Hospital. J Med Assoc Thailand. 2002;85(Suppl 4):S1252-S1258.
137. Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomised controlled trial. Eur J Pediatr. 2002;161:202-207.
138. Patel J, Roberts I, Azzopardi D, et al. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res. 2000;47:36-42.
139. Pezzati M, Vangi V, Biagiotti R, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr. 1999;135:733-738.
140. Mosca F, Bray M, Lattanzio M, et al. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr. 1997;131:549-554.
141. Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2003:CD004213.
142. Goumay V, Savagner C, Thiriez G, et al. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet. 2002;359:1486-1488.
143. Dsida RM, Wheeler M, Birmingham PK, et al. Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients. Anesth Analg. 2002;94:266-270.
144. Burd RS, Tobias JD. Ketorlac for pain management after abdominal surgical procedures in infants. South Med J. 2002;95:331-333.
145. Buck ML, Norwood VF. Ketorolac-induced acute renal failure in a previously healthy adolescent. Pediatrics. 1996;98:294-296.
146. Houck CS, Wilder RT, McDermott JS, et al. Safety of intravenous ketorolac therapy in children and cost savings with a unit dosing system. J Pediatr. 1996;129:292-296. Comment.
147. Rusy LM, Houck CS, Sullivan LJ, et al. A double-blind evaluation of ketorolac tromethamine versus acetaminophen in pediatric tonsillectomy: Analgesia and bleeding. Anesth Analg. 1995;80:226-229.
148. Leese PT, Hubbard RC, Karim A, et al. Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial. J Clin Pharmacol. 2000;286:124-132.
149. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286:954-959.
150. Sheeran PW, Rose JB, Fazi LM, et al. Rofecoxib administration to paediatric patients undergoing adenotonsillectomy. Paediatr Anaesth. 2004;14:579-583.
151. Stempak D, Gammon J, Klein J, et al. Single-dose and steady-state pharmacokinetics of celecoxib in children. Clin Pharmacol Ther. 2002;72: 490-497.
152. Henderson K, Sethna NF, Berde CB. Continuous caudal anesthesia for inguinal hernia repair in former preterm infants. J Clin Anesth. 1993; 5:129-133.
153. Murrell D, Gibson PR, Cohen RC. Continuous epidural analgesia in newborn infants undergoing major surgery. J Pediatr Surg. 1993;28: 548-552.
154. Lander J, Brady-Fryer B, Metcalfe JB, et al. Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: A randomized controlled trial. JAMA. 1997;278:2157-2162.
155. Berde CB. Convulsions associated with pediatric regional anesthesia. Anesth Analg. 1992;75:164-166.
156. Maxwell LG, Martin LD, Yaster M. Bupivacaine-induced cardiac toxicity in neonates: Successful treatment with intravenous phenytoin. Anesthesiology. 1994;80:682-686.
157. Mazoit JX, Denson DD, Samii K. Pharmacokinetics of bupivacaine following caudal anesthesia in infants. Anesthesiology. 1988;68:387-391.
158. Mazoit JX, Dalens BJ. Pharmacokinetics of local anaesthetics in infants and children. Clin Pharmacology. 2004;43:17-32.
159. Larsson BA, Lonnqvist PA, Olsson GL. Plasma concentrations of bupivacaine in neonates after continuous epidural infusion. Anesth Analg. 1997;84:501-505.
160. Oberlander TF, Berde CB, Lam KH, et al. Infants tolerate spinal anesthesia with minimal overall autonomic changes: Analysis of heart rate variability in former premature infants undergoing hernia repair. Anesth Analg. 1995;80:20-27.
161. Rochette A, Raux O, Troncin R, et al. Clonidine prolongs spinal anesthesia in newborns: A prospective dose-ranging study. Anesth Analg. 2004;98:56-59.
162. Kohane DS, Sankar WN, Shubina M, et al. Sciatic nerve blockade in infant, adolescent, and adult rats: A comparison of ropivacaine with bupivacaine. Anesthesiology. 1998;89: 1199-1208.
163. Hu D, Hu R, Berde CB. Neurologic evaluation of infant and adult rats before and after sciatic nerve blockade. Anesthesiology. 1997;86: 957-965.
164. Curatolo M, Petersen-Felix S, Scaramozzino P, Zbinden AM. Epidural fentanyl, adrenaline and clonidine as adjuvants to local anaesthetics for surgical analgesia: Meta-analyses of analgesia and side-effects. Acta Anaesthesia Scand. 1998;42:910-920.
165. Constant I, Gall O, Gouyet L, et al. Addition of clonidine or fentanyl to local anaesthetics prolongs the duration of surgical analgesia after single shot caudal block in children. Br J Anaesth. 1998;80:294-298.
166. Bailey PL, Sperry RJ, Johnson GK, et al. Respiratory effects of clonidine alone and combined with morphine, in humans. Anesthesiology. 1991;74:43-48.
167. 2 tension effects of clonidine in paediatric caudal analgesia. Paediatr Anaesth. 1998;8:145-148.
168. Eisenach JC, Dewan DM. Intrathecal clonidine in obstetrics: Sheep studies. Anesthesiology. 1990;72:663-668.
169. Claes B, Soetens M, Van Zundert A, Datta S. Clonidine added to bupivacaine-epinephrine-sufentanil improves epidural analgesia during childbirth. Reg Anesth Pain Med. 1998;23:540-547.
170. De Negri P, Ivani C, Visconti C, et al. The dose-response relationship for clonidine added to a postoperative continuous epidural infusion of ropivacaine in children. Anesth Analg. 2001;93:71-76.
171. De Negri P, Ivani G, Visconti C, De Vivo P. How to prolong postoperative analgesia after caudal anaesthesia with ropivacaine in children: S-ketamine versus clonidine. Paediatr Anaesth. 2001;11:679-683.
172. (+)-ketamine in children. Anesth Analg. 2002;94: 1169-1172.
173. Ivani G, De Negri P, Conio A, et al. Ropivacaine-clonidine combination for caudal blockade in children. Acta Anaesthesiol Scand. 2000; 44:446-449.
174. Klamt JG, Garcia LV, Stocche RM, Meinberg AC. Epidural infusion of clonidine or clonidine plus ropivacaine for postoperative analgesia in children undergoing major abdominal surgery. J Clin Anesth. 2003;15: 510-514.
175. -1 for post-operative caudal analgesia in children. Eur J Anaesthesiol. 1999;16:42-46.
176. Lee JJ, Rubin AP. Comparison of a bupivacaine-donidine mixture with plain bupivacaine for caudal analgesia in children. Br J Anaesth. 1994; 72:258-262.
177. Eisenach JC, Lysak SZ, Viscomi CM. Epidural clonidine analgesia following surgery: Phase I. Anesthesiology. 1989;71:640-646.
178. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chlorprocaine injection. Anesth Analg. 1980;59:452-454.
179. Taniguchi M, Bollen AW, Drasner K. Sodium bisulfite: Scapegoat for chloroprocaine neurotoxicity? Anesthesiology. 2004;100:85-91.
180. Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: A comparison with lidocaine in volunteers. Anesth Analg. 2004;98:75-80.
181. Giaufre E, Dalens B, Gombert A. Epidemiology and morbidity of regional anesthesia in children: A one-year prospective survey of the French-Language Society of Pediatric Anesthesiologists. Anesth Analg. 1996; 83:904-912.
182. Tsui BC. Thoracic epidural catheter placement in infants via the caudal approach under electrocardiographic guidance: Simplification of the original technique. Anesth Analg. 2004;98:273.
183. Tsui BC, Guenther C, Emery D, Finucane B. Determining epidural catheter location using nerve stimulation with radiological confirmation. Reg Anesth Pain Med. 2000;25: 306-309.
184. Tsui BC, Seal R, Koller J, et al. Thoracic epidural analgesia via the caudal approach in pediatric patients undergoing fundoplication using nerve stimulation guidance. Anesth Analg. 2001;93:1152-1155.
185. Tsui BC, Seal R, Koller J. Thoracic epidural catheter placement via the caudal approach in infants by using electrocardiographic guidance. Anesth Analg. 2002;95:326-330.
186. Goobie SM, Montgomery CJ, Basu R, et al. Confirmation of direct epidural catheter placement using nerve stimulation in pediatric anesthesia. Anesth Analg. 2003;97:984-988.
187. Berde C. Local anesthetics in infants and children: An update. Paediatr Anaesth. 2004;14:387-393.
188. Tobias JD, Rasmussen GE, Holcomb GW III, et al. Continuous caudal anaesthesia with chloroprocaine as an adjunct to general anaesthesia in neonates. Can J Anaesth. 1996;43:69-72.
189. Spencer DM, Miller KA, O'Quin M, et al. Dorsal penile nerve block in neonatal circumcision: Chloroprocaine versus lidocaine. Am J Perinatol. 1992;9:214-218.